Broughton CEO, Chris Allen, has written a letter to the Editor of The Grocer in response to a recent article they published about underage vaping.

Helping you bring reduced risk products, including e-cigarettes, heated tobacco products, and modern oral nicotine pouches, to market to drive tobacco harm reduction. Our experienced scientists will help build the evidence needed to satisfy regulators’ expectations of reduced risk.
We also have extensive experience generating evidence to support nicotine replacement therapies such as pouches and gums.
Whatever your next generation nicotine delivery product (NGP) or Nicotine Replacement Therapy (NRT) testing requirements, we have the expertise and regulatory insight to build a scientific testing strategy that ensures complete but efficient product understanding and regulatory compliance. Whether you are looking for a partner to work with on a new R&D project, a regulatory submission, or to strengthen scientific understanding for post market purposes, our subject matter experts will add deep insight to your project built from their years of industry experience.
Bespoke analytical method development and validation using cutting-edge technology and equipment.
Helping manage the quality and safety of products throughout their lifecycle with QC release testing and investigatory analysis to guarantee product quality and the protection of public health.
Designing stability studies in support of nicotine-related R&D projects, regulatory applications, and post market compliance with in-house analytical expertise to interpret data and troubleshoot.
Identifying and measuring Harmful and Potentially Harmful Constituents (HPHCs) that may be produced or consumed when using a nicotine-based consumer or medicinal product.
Understanding and reducing the health risks of your NGP. Toxicology risk assessment of the materials and ingredients of your product is important at each stage of a next generation nicotine delivery development project, from R&D to regulatory submissions and post market compliance.
Ensuring a full understanding of the potential leachable compounds and their toxicity that may leach into a nicotine product from its container closure system, manufacturing process, or packaging.
Whatever your nicotine product category, we can support you with a comprehensive testing strategy that helps build the scientific evidence and insight needed to gain regulatory approval and consumer trust. Our scientific experts have extensive experience across all forms of consumer next generation nicotine delivery products (NGPs) and medicinal nicotine replacement therapies (NRTs).
Learn more about how we can help bring your nicotine delivery product to market through our high-quality analytical testing services.
At Broughton, our consultants have deep industry knowledge across all the elements required for a PMTA. We guide you through and generate the required data, to ensure that FDA finds your applications strong and compelling.
Learn more about our activities and gain insight from our scientific and regulatory experts
1 minute read
Broughton CEO, Chris Allen, has written a letter to the Editor of The Grocer in response to a recent article they published about underage vaping.